Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metro Vein Centers operates over fifty accredited clinics across the United States providing FDA-approved, minimally invasive treatments for vein diseases. The company has treated more than 100,000 patients with high satisfaction rates and offers personalized care plans using state-of-the-art technology. Treatments include laser ablation, radiofrequency ablation, sclerotherapy injections, and VenaSeal® adhesive closure. Most procedures are covered by insurance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metro Vein Centers.